Sort
16,179 grants matching “malaria”
Understanding Innate Immune Recognition and IFN-g-Mediated Immunity in Cryptosporidiosis
$707,782Felix Yarovinsky · University Of Rochester · R01 · FY2025 · AI
Understanding Innate Immune Recognition and IFN-g-Mediated Immunity in Cryptosporidiosis
$707,782Felix Yarovinsky · University Of Rochester · R01 · FY2024 · AI
Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery
$707,737Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2021 · AI
Chemosensory Mechanisms Driving Malaria Transmission
$707,696Conor James McMeniman · Johns Hopkins University · R01 · FY2025 · AI
Novel Broad-spectrum Antimalarials
$707,637Jane X Kelly · Portland State University · R01 · FY2015 · AI
Optimization of antimalarials targeting multiple life stages of the parasite
$707,225Paul R Carlier · University Of Illinois At Chicago · R01 · FY2023 · AI
Increasing available choices for conjugate vaccine technology by producing carrier proteins in Scarab Genomicsâ reduced genome E. coli strains
$706,927Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2018 · AI
MBRS SCORE Program at UPR, Medical Sciences Campus
$706,916University Of Puerto Rico Med Sciences · S06 · FY2002 · GM
Defining targets of protective immunity to vivax malaria using human monoclonal antibodies
$706,868Christopher L King · Case Western Reserve University · R01 · FY2023 · AI
A universal malaria T cell vaccine based on HLA-E presentation
$706,784Brandon Keith Wilder · Oregon Health & Science University · R01 · FY2025 · AI
Defining targets of protective immunity to vivax malaria using human monoclonal antibodies
$706,742Christopher L King · Case Western Reserve University · R01 · FY2022 · AI
Regulation of RANTES expression in T lymphocytes
$706,570Alan Krensky · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Function of granulysin
$706,570Alan Krensky · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Hit-to-Lead Development of the Kalihinol Scaffold for Malaria Treatment
$706,539Christopher D Vanderwal · University Of California-Irvine · R01 · FY2021 · AI
MONITORING & EVALUATION OF MALARIA ACTIVITIES IN THE GREATER MEKONG SUBREGION U01
$706,500Sylvia Meek · Malaria Consortium · U01 · FY2010 · CK
The temporal reconfiguration of regulatory networks: From yeast to cancer
$706,419Aviv Regev · Massachusetts Institute Of Technology · DP1 · FY2008 · OD
Host and parasite factors influencing P. vivax RBC invasion and asexual development
$706,316David Serre · University Of Maryland Baltimore · R01 · FY2023 · AI
Human mobility models to forecast disease dynamics and the effectiveness of public health interventions
$706,315Amy Wesolowski · Johns Hopkins University · R01 · FY2021 · AI
Vaccine-Induced Immunity to CMV
$706,056Don J Diamond · Beckman Research Institute/City Of Hope · P01 · FY2010 · CA
Understanding Emerging artemisinin partner drug resistance in eastern Africa
$705,896Michael T Ferdig · University Of Notre Dame · R01 · FY2025 · AI
Redefining thermal suitability for urban malaria transmission in the context of humidity
$705,856Courtney Murdock · Cornell University · R01 · FY2024 · AI
DRUG DEVELOPMENT AND CONSERVATION OF BIODIVERSITY IN WES
$705,600U.S. Walter Reed Army Inst Of Research · U01 · FY2002 · TW
Mechanisms of endothelial dysfunction in cerebral malaria and barrier restorative pathways
$705,576Joseph D Smith · Seattle Children'S Hospital · R01 · FY2023 · AI
Mechanisms of endothelial dysfunction in cerebral malaria and barrier restorative pathways
$705,576Joseph D Smith · Seattle Children'S Hospital · R01 · FY2024 · AI
Multifidelity and multiscale modeling of the spleen function in sickle cell disease with in vitro, ex vivo and in vivo validations
$705,243George Karniadakis · Brown University · R01 · FY2020 · HL